Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits

Akihiro Matsukawa, S. Ohkawara, T. Maeda, K. Takagi, M. Yoshinaga

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Injection of lipopolysaccharide (LPS) into rabbit knee joints provoked leucocyte infiltration and loss of proteoglycan (PG) from the cartilage. We investigated the role of IL-1 and IL-1 receptor antagonist (IL-1Ra) and its significance in the pathogenesis of LPS-arthritis. Production of IL-1β peaked at 6 h (196.7 ± 89.4 pg/joint) after injection of 10 ng of LPS, while IL-1Ra peaked at 9 h (34.5 ± 13.4 ng/joint). The amount of IL-1Ra was 180-200-fold molar excess of IL-1, and a large amount of IL-1Ra was sustained for 1 week. Both IL-1β and IL-1Ra were mainly produced by synovial exudate cells. Arthritis was reproduced by rabbit IL-1β. LPS-induced leucocyte infiltration was inhibited 70-75% by rabbit IL-1Ra. Loss of PG in LPS-arthritis was prevented by IL-1Ra and also by neutrophil elastase inhibitor, and superoxide dismutase. In leucopenic rabbits, injection of LPS induced neither production of IL-1β nor loss of PG. Direct injection of inflammatory exudated cells in leucopenic rabbits reproduced loss of PG, and there was only a partial recovery by IL-1Ra. These results suggest that LPS-initiated IL-1 acts as a key mediator in LPS-arthritis and that endogenous IL-1Ra may suppress a part of IL-1 activity at the site, but its amount was too low for suppression of the produced IL-1. Loss of PG is a sequela of infiltrated leucocytes and leucocyte-derived elastase, and superoxide anion may play a pivotal role in the destruction of cartilage.

Original languageEnglish
Pages (from-to)206-211
Number of pages6
JournalClinical and Experimental Immunology
Volume93
Issue number2
Publication statusPublished - 1993
Externally publishedYes

Fingerprint

Interleukin-1 Receptors
Interleukin-1
Arthritis
Lipopolysaccharides
Rabbits
Proteoglycans
Injections
Leukocytes
Cartilage
Secretory Proteinase Inhibitory Proteins
Joints
Leukocyte Elastase
Exudates and Transudates
Knee Joint
Superoxides
Superoxide Dismutase

Keywords

  • cytokine production in vivo
  • leucocyte infiltration
  • neutrophil elastase
  • proteoglycan degradation
  • superoxide anion

ASJC Scopus subject areas

  • Immunology

Cite this

Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. / Matsukawa, Akihiro; Ohkawara, S.; Maeda, T.; Takagi, K.; Yoshinaga, M.

In: Clinical and Experimental Immunology, Vol. 93, No. 2, 1993, p. 206-211.

Research output: Contribution to journalArticle

@article{a955963d5af04a589ce1aa0896b5b9ad,
title = "Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits",
abstract = "Injection of lipopolysaccharide (LPS) into rabbit knee joints provoked leucocyte infiltration and loss of proteoglycan (PG) from the cartilage. We investigated the role of IL-1 and IL-1 receptor antagonist (IL-1Ra) and its significance in the pathogenesis of LPS-arthritis. Production of IL-1β peaked at 6 h (196.7 ± 89.4 pg/joint) after injection of 10 ng of LPS, while IL-1Ra peaked at 9 h (34.5 ± 13.4 ng/joint). The amount of IL-1Ra was 180-200-fold molar excess of IL-1, and a large amount of IL-1Ra was sustained for 1 week. Both IL-1β and IL-1Ra were mainly produced by synovial exudate cells. Arthritis was reproduced by rabbit IL-1β. LPS-induced leucocyte infiltration was inhibited 70-75{\%} by rabbit IL-1Ra. Loss of PG in LPS-arthritis was prevented by IL-1Ra and also by neutrophil elastase inhibitor, and superoxide dismutase. In leucopenic rabbits, injection of LPS induced neither production of IL-1β nor loss of PG. Direct injection of inflammatory exudated cells in leucopenic rabbits reproduced loss of PG, and there was only a partial recovery by IL-1Ra. These results suggest that LPS-initiated IL-1 acts as a key mediator in LPS-arthritis and that endogenous IL-1Ra may suppress a part of IL-1 activity at the site, but its amount was too low for suppression of the produced IL-1. Loss of PG is a sequela of infiltrated leucocytes and leucocyte-derived elastase, and superoxide anion may play a pivotal role in the destruction of cartilage.",
keywords = "cytokine production in vivo, leucocyte infiltration, neutrophil elastase, proteoglycan degradation, superoxide anion",
author = "Akihiro Matsukawa and S. Ohkawara and T. Maeda and K. Takagi and M. Yoshinaga",
year = "1993",
language = "English",
volume = "93",
pages = "206--211",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits

AU - Matsukawa, Akihiro

AU - Ohkawara, S.

AU - Maeda, T.

AU - Takagi, K.

AU - Yoshinaga, M.

PY - 1993

Y1 - 1993

N2 - Injection of lipopolysaccharide (LPS) into rabbit knee joints provoked leucocyte infiltration and loss of proteoglycan (PG) from the cartilage. We investigated the role of IL-1 and IL-1 receptor antagonist (IL-1Ra) and its significance in the pathogenesis of LPS-arthritis. Production of IL-1β peaked at 6 h (196.7 ± 89.4 pg/joint) after injection of 10 ng of LPS, while IL-1Ra peaked at 9 h (34.5 ± 13.4 ng/joint). The amount of IL-1Ra was 180-200-fold molar excess of IL-1, and a large amount of IL-1Ra was sustained for 1 week. Both IL-1β and IL-1Ra were mainly produced by synovial exudate cells. Arthritis was reproduced by rabbit IL-1β. LPS-induced leucocyte infiltration was inhibited 70-75% by rabbit IL-1Ra. Loss of PG in LPS-arthritis was prevented by IL-1Ra and also by neutrophil elastase inhibitor, and superoxide dismutase. In leucopenic rabbits, injection of LPS induced neither production of IL-1β nor loss of PG. Direct injection of inflammatory exudated cells in leucopenic rabbits reproduced loss of PG, and there was only a partial recovery by IL-1Ra. These results suggest that LPS-initiated IL-1 acts as a key mediator in LPS-arthritis and that endogenous IL-1Ra may suppress a part of IL-1 activity at the site, but its amount was too low for suppression of the produced IL-1. Loss of PG is a sequela of infiltrated leucocytes and leucocyte-derived elastase, and superoxide anion may play a pivotal role in the destruction of cartilage.

AB - Injection of lipopolysaccharide (LPS) into rabbit knee joints provoked leucocyte infiltration and loss of proteoglycan (PG) from the cartilage. We investigated the role of IL-1 and IL-1 receptor antagonist (IL-1Ra) and its significance in the pathogenesis of LPS-arthritis. Production of IL-1β peaked at 6 h (196.7 ± 89.4 pg/joint) after injection of 10 ng of LPS, while IL-1Ra peaked at 9 h (34.5 ± 13.4 ng/joint). The amount of IL-1Ra was 180-200-fold molar excess of IL-1, and a large amount of IL-1Ra was sustained for 1 week. Both IL-1β and IL-1Ra were mainly produced by synovial exudate cells. Arthritis was reproduced by rabbit IL-1β. LPS-induced leucocyte infiltration was inhibited 70-75% by rabbit IL-1Ra. Loss of PG in LPS-arthritis was prevented by IL-1Ra and also by neutrophil elastase inhibitor, and superoxide dismutase. In leucopenic rabbits, injection of LPS induced neither production of IL-1β nor loss of PG. Direct injection of inflammatory exudated cells in leucopenic rabbits reproduced loss of PG, and there was only a partial recovery by IL-1Ra. These results suggest that LPS-initiated IL-1 acts as a key mediator in LPS-arthritis and that endogenous IL-1Ra may suppress a part of IL-1 activity at the site, but its amount was too low for suppression of the produced IL-1. Loss of PG is a sequela of infiltrated leucocytes and leucocyte-derived elastase, and superoxide anion may play a pivotal role in the destruction of cartilage.

KW - cytokine production in vivo

KW - leucocyte infiltration

KW - neutrophil elastase

KW - proteoglycan degradation

KW - superoxide anion

UR - http://www.scopus.com/inward/record.url?scp=0027165586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027165586&partnerID=8YFLogxK

M3 - Article

C2 - 8348745

AN - SCOPUS:0027165586

VL - 93

SP - 206

EP - 211

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 2

ER -